70934-0809 Ondansetron

Product NDC:

70934-0809

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

TABLET, ORALLY DISINTEGRATING

Administration Route:

Oral

Substances:

Name: ONDANSETRON

Strength: 8.0

Unit: mg/1

Packages:

Code: 70934-0809-83

Description: 4 TABLET, ORALLY DISINTEGRATING in 1 BAG (70934-809-83)

Effective Date: April 22, 2021

Discontinued: Feb. 28, 2025

Code: 70934-0809-87

Description: 6 TABLET, ORALLY DISINTEGRATING in 1 BAG (70934-809-87)

Effective Date: April 22, 2021

Discontinued: Feb. 28, 2025

Code: 70934-0809-88

Description: 8 TABLET, ORALLY DISINTEGRATING in 1 BAG (70934-809-88)

Effective Date: Aug. 16, 2021

Discontinued: Nov. 30, 2024

Code: 70934-0809-95

Description: 10 TABLET, ORALLY DISINTEGRATING in 1 BAG (70934-809-95)

Effective Date: Dec. 8, 2020

Discontinued: Feb. 28, 2025

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

No

Status:

In Use

CanMED and the Oncology Toolbox